Effect of Cryotherapy on Postoperative Pain After Hemorrhoidectomy: A Randomized Controlled Trial
| Registry | NCT07714122 |
|---|---|
| Status | Not yet recruiting |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: double, treatment |
| Enrollment | 114 (Estimated) |
| Sponsor | Cairo University (Other) |
| Conditions | Hemorrhoid, Hemorrhoidectomy |
| Interventions | Milligan-Morgan Hemorrhoidectomy with Cryotherapy, Miligan-Morgan haemorroidectomy (Procedure) |
| Dates | start 2026-08-04 (estimated), primary completion 2027-06-01 (estimated), completion 2027-06-01 (estimated), first posted 2026-07-20, last updated 2026-07-22 |
| Locations | 1 site in Egypt |
Related Papers Related Patents Related Grants Related Experts
All trials for Hemorrhoid All trials for Hemorrhoidectomy All trials of Milligan-Morgan Hemorrhoidectomy with Cryotherapy All trials of Miligan-Morgan haemorroidectomy
This prospective, patient-blinded randomized controlled trial will be conducted at Kasr Al-Ainy Hospital, Cairo University. Adult patients with grade III or IV hemorrhoids undergoing elective surgery will be randomized (1:1) to either conventional hemorrhoidectomy or hemorrhoidectomy followed by intra-anal cryotherapy. All patients will undergo standardized preoperative assessment and receive the same postoperative analgesia and care. Postoperative pain will be assessed using the Visual Analogue Scale (VAS), with follow-up at postoperative day 2 and at 1, 2, 3, and 4 weeks.
This prospective, patient-blinded randomized controlled trial will be conducted at the General Surgery Department, Kasr Al-Ainy Hospital, Cairo University. Adult patients (≥18 years) with grade III or IV hemorrhoids who are scheduled for elective surgery will be enrolled. Patients with concomitant anorectal pathology, inflammatory bowel disease, impaired continence, or those requiring synchronous procedures will be excluded.
Following informed consent, all patients will undergo standardized preoperative clinical assessment and routine laboratory investigations, with colonoscopy performed when clinically indicated. Participants will be randomized in a 1:1 ratio using computer-generated randomization with allocation concealment by sequentially numbered, opaque, sealed envelopes into either conventional Milligan-Morgan hemorrhoidectomy (control group) or Milligan-Morgan hemorrhoidectomy followed by intra-anal cryotherapy (cryotherapy group). In the cryotherapy group, a sterile ice pack will be inserted into the anal canal for 1 minute immediately after completion of hemorrhoidectomy.
Postoperative management will be standardized in both groups, including analgesia, local care, antibiotics, and laxatives. Postoperative Pain will be assessed using the Visual Analogue Scale (VAS).
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Miligan-Morgan haemorroidectomy with Crytherapy | Experimental | Procedure: Milligan-Morgan Hemorrhoidectomy with Cryotherapy | Patients will be conducted to Miligan-Morgan haemorroidectomy with intraoperative Crytherapy |
| Miligan-Morgan haemorroidectomy | Active comparator | Procedure: Miligan-Morgan haemorroidectomy | Patients will be conducted to Milligan-Morgan Hemorrhoidectomy |
Sex: All, ages: 18 Years to any
Inclusion Criteria: * Patients with with third or fourth degree haemorrhoids for elective Haemorrhoidectomy and their age greater than 18 years old. Exclusion Criteria: * Concurrent anal pathology (e.g., anal fissure, fistula, ) * Patients planned for synchronous procedures * Patients with inflammatory bowel disease * Patients with impaired anal sphincter function or fecal incontinence
| Facility | City | Country | Status |
|---|---|---|---|
| Faculty of medicine, Cairo University | Cairo, Al-Manial, Cairo, Egypt | Egypt |